Acr Alpine Capital Research, LLC Johnson & Johnson Transaction History
Acr Alpine Capital Research, LLC
- $4.28 Billion
- Q4 2024
A detailed history of Acr Alpine Capital Research, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Acr Alpine Capital Research, LLC holds 1,840,237 shares of JNJ stock, worth $299 Million. This represents 6.22% of its overall portfolio holdings.
Number of Shares
1,840,237
Previous 1,184,419
55.37%
Holding current value
$299 Million
Previous $192 Million
38.65%
% of portfolio
6.22%
Previous 6.15%
Shares
33 transactions
Others Institutions Holding JNJ
# of Institutions
4,509Shares Held
1.73BCall Options Held
16.8MPut Options Held
13.9M-
Vanguard Group Inc Valley Forge, PA233MShares$37.8 Billion0.6% of portfolio
-
Black Rock Inc. New York, NY198MShares$32.2 Billion0.67% of portfolio
-
State Street Corp Boston, MA134MShares$21.8 Billion0.79% of portfolio
-
Geode Capital Management, LLC Boston, MA57.7MShares$9.36 Billion0.66% of portfolio
-
Morgan Stanley New York, NY43.9MShares$7.13 Billion0.46% of portfolio
About JOHNSON & JOHNSON
- Ticker JNJ
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,614,479,872
- Market Cap $424B
- Description
- Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...